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Abstract

Background: Prior to recent restrictions on travel, international travel was popular with an
increasing number of U.S. residents traveling to emerging markets, which may have unfamiliar
health risks. In additional to risk of illness, travelers may carry nonendemic disease across
country borders, increasing risks to public health. Problem: Though many international travelers
report illness during travel or after returning home, only a portion receive a pretravel health
consult for preventive care and education. Newer recommendations are to screen for upcoming
international travel during routine health contacts; however, a travel medicine provider is best
able to perform a comprehensive risk assessment and provide appropriate care. Methods: All
adult patients were to be screened for upcoming international travel during each primary care
visit at all University of Pittsburgh Medical Center (UPMC) Pinnacle primary care sites –
referrals to the Travel Medicine Clinic (TMC) were then given as appropriate. Intervention: A
tool to screen for upcoming international travel was embedded into the electronic medical record
(EMR) at primary care visits with answers recorded by the rooming medical assistant. For
patients with positive screenings, the provider received an immediate EMR prompt for a TMC
referral. Results: Analysis of a total quota sample (n=200) found a significant increase in
referrals to the TMC [x2(1) = 118.7, p = .000] with a large effect size (d = .770) in the postintervention group. Additionally, asking about upcoming international travel does have a
statistically significant effect on referrals to the TMC [pre group: 0%, n = 0; post group: 93.8%,
n – 75, x2(2) = 29.18, p = .000] with a strong positive association noted (r = .59). Conclusion:
Screening for upcoming international travel at primary care visits does increase referrals to the
TMC, potentially decreasing risks to travelers and public health.
Keywords: travel medicine, preventive care, pre-travel consult, travel health, travel-related illness
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Improving Preventive Care for International Travelers through Primary Care Screening
Background
Prior to recent restrictions on travel, the popularity of international travel was evident as
approximately 41.77 million individuals traveled outside the U.S. in 2018 (National Travel and
Tourism Office [NTTO], 2020). Additionally, the number of individuals who travel,
specifically, from the U.S. to emerging markets and developing countries, which often have
unique health risks, is increasing (Angelo, Kozarsky, Ryan, Chen, & Sotir, 2017a; Walker, et al.,
2017). Included in this number is the large wave of immigrants to the U.S. – foreign-born
persons who return to their countries of birth to visit friends and relatives (VFRs; Hamer et al.,
2017; Tan et al., 2017) - who, unfortunately, suffer the highest rate of travel-related morbidity
(Freedman, Chen, & Kozarsky, 2016). All international travelers may be exposed to health risks
and unfamiliar diseases not endemic to their own country, for which they have no preventive
care or education, potentially suffering morbidity and/or mortality as a result (Hagmann et al.,
2014; Omodior, Pennington-Gray, Holland, Thapa, & Kiousis, 2017). Additionally, travelers
can carry nonendemic diseases across borders, exposing others to secondary disease and
increasing risks to public health (Laroque et al., 2010; Walker et al., 2017). Authors, Harvey et
al. (2013), published a sentinel study in which they noted, “travelers have contributed to the
global spread of infectious diseases, including novel and emerging pathogens” (p. 1). This risk
has most recently been realized in coronavirus disease 2019 (COVID-19), first identified in
Wuhan, China in 2019 (Centers for Disease Control and Prevention [CDC], 2020), which
quickly spread globally through international travel and was declared a pandemic in March 2020
(World Health Organization [WHO], 2020).
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Problem Statement

Although overall rates of international travel-related illness vary, a literature review noted
that among travelers visiting developing countries, 43-79% developed a travel-related illness
during travel or after returning home (Angelo et al., 2017b). Additionally, 53-56% of all
international travelers with a travel-related illness never received a pre-travel health consult
(Angelo et al., 2017b; Hagmann et al., 2014; Harvey et al., 2013). Unique to the subset of
students (ages 17-24) who traveled for educational purposes to resource-limited countries, 70%
had received a pre-travel health consult (Angelo et al., 2018). To increase preventive care and
education, a recommendation by Angelo et al. (2017b) and Tan et al. (2017) includes proactive
screening for international travel during routine patient contacts. However, due to complex
epidemiology and the dynamic nature of travel medicine, unless a primary care provider - whose
offices generally do not carry many of the preventive immunizations recommended for certain
travel destinations (Freedman & Leder, 2018) - can complete a comprehensive risk assessment
and fully understands the traveler-specific, itinerary-specific, and destination-specific risks, the
patient should be referred to a travel medicine specialist (Chen et al., 2018; Fischer, 2017;
Zappas, Whitely, & Carter, 2019).
Because there was no screening at University of Pittsburgh Medical Center (UPMC)
Pinnacle primary care sites for international travel, this quality improvement (QI) project focused
on improving preventive care prior to international travel through screening during the rooming
process at each adult primary care visit. PICO(T) Question: For adult patients at UPMC
Pinnacle primary care clinics (P), how does screening for upcoming international travel at each
primary care encounter (I) compare to no screening for international travel at each primary care
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encounter (C) influence the number of patients referred from primary care to the Travel
Medicine Clinic (TMC) (O) over an 8-month period (T)?
Needs Assessment
According to the literature, both content and context issues were present. These included
an overall lack of public knowledge regarding the need for pre-travel preventive care as well as a
lack of coordination in patients receiving this recommended care. A SWOT analysis (Appendix
A) reveals internal strengths and weaknesses as well as external opportunities and threats.
Strengths included the large size of the UPMC Pinnacle network with an associated
TMC. UPMC Pinnacle TMC employs knowledgeable providers to manage travel-related
illnesses as well as to provide comprehensive pre-travel preventive care (UPMC Pinnacle,
2019b). Trained referral team members direct referrals from providers to the TMC efficiently;
however, a weakness is present as TMC intake staff only provide estimated costs to the referred
individual based on travel destination and are not educated to advise on risks if a patient declines
an appointment because of costs. Additionally, staffing vacancies throughout the organization
strain resources system wide.
Opportunities for improvement existed due to the large local immigrant
community/VFRs – in two main counties the largest group was from Asia with a total population
of approximately 17,400 individuals - who often travel to their country of origin and have a
uniquely high risk of morbidity related to their travel (Freedman et al., 2016; Migration Policy
Initiative [MPI], 2017), as well as the large number of international travelers (Angelo et al.,
2017b; Walker et al., 2017). Opportunities also surrounded media coverage of infectious disease
outbreaks (i.e. Ebola) which improved public awareness and provided an increased opportunity
for disease prevention (World Health Organization [WHO], 2018). Threats to improvement
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existed as traditional insurance coverage does not pay for preventive immunizations or
medication related to voluntary travel; thus, individuals may decline preventive care and
medications due to out-of-pocket costs (Angelo et al., 2017a; Bunn, 2015). A root cause analysis
replicated the issues identified through the SWOT analysis (see Appendix B).
One identified core value of UPMC Pinnacle – safety – aligns with this project through
preventing primary illness in travelers and, further, preventing secondary illness to staff, other
patients, and the community (UPMC Pinnacle, 2019c). This QI project, consistent with the six
domains of health care quality, was to be (a) safe, (b) effective, (c) patient-centered, (d) timely,
(e) efficient, and (f) equitable (Agency for Healthcare Research and Quality [AHRQ], 2018).
Aims, Objectives, Purpose Statement
The overarching aim for this project was to increase the number of patients, who have
upcoming international travel, referred to the TMC. The SMART objectives included: (a)
embedded screening questions regarding upcoming international travel added to the electronic
medical record (EMR) rooming template, (b) screening 100% of adult patients for upcoming
international travel at all primary care visits from May 2018 through January 2020, (c) offering a
TMC referral to all patients who admitted to upcoming international travel, and (d) providing an
automated TMC referral for the provider to sign for all amenable patients (see Appendix C).
Thus, the overall purpose of this project was to increase the number of patients, planning to
participate in international travel, who receive travel-related preventive care and education.
Review of Literature
A review of applicable literature included a search through Medline Complete and
CINAHL with inclusion limits, based on the project specifics, of: (a) English language; (b) USA
geographic subset; and (c) 2014-2019 publishing dates. Additional records were identified
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through Google Scholar®, UpToDate®, and the Centers for Disease Control and Prevention
(CDC) leading to a total combination of 731 records screened, 38 full-text articles assessed for
eligibility, and 17 final articles included for relevance and quality (see Appendix D). Final
articles, appraised using the Johns Hopkins Evidence-Based Practice Model (Dearhold & Dang,
2012), included research and non-research evidence (levels III through V) with quality ratings of
A or B and the resulting data was combined in an evidence matrix summary (see Appendix E).
Common themes included: (a) the lack of pre-travel medical consults for international
travelers, (b) the recommendation of screening for upcoming international travel during routine
healthcare visits, (c) the need for a pre-travel consult for international travelers to prevent
primary disease and secondary illness in the community, and (d) the need for a provider with
specialized knowledge of travel medicine to provide comprehensive care. Except students
traveling for academic purposes, non-experimental and descriptive research evidence reported
only 44-47% of international travelers sought out a medical consult prior to their travel (Angelo
et al, 2017b; Hagmann et al., 2014; Harvey et al., 2013). Research authors Angelo et al. (2017a)
and Tan et al. (2017) recommended screening for upcoming international travel during routine
health care visits to increase preventive care. Additionally, the need for a medical consult before
international travel was well supported throughout the evidence from clinical practice guidelines
(Freedman & Leder, 2018; Lee et al., 2017), expert opinion (Freedman et al., 2016), and research
data (Chen et al., 2018; Harvey et al., 2013; Laroque et al., 2010). Finally, most pre-travel
medical consults should be completed by a provider with specialized knowledge of travel
medicine to provide comprehensive care based on traveler-specific, itinerary-specific, and
destination-specific risks – which is supported by research evidence (Chen et al., 2018;
Freedman et al., 2018) as well as published clinical practice guidelines (Fischer, 2017), expert

IMPROVING PREVENTIVE CARE

10

opinion (Sanford, McConnell, & Osborn, 2016) and community standards (Zappas et al., 2019).
An evidence-based need for improvement in preventive care prior to international travel was
demonstrated in this literature review. Excepting two sentinel studies by Harvey et al. (2013)
and LaRoque et al. (2010), all literature evidence was published within five years of proposal. A
notable gap was observed in the literature regarding benchmarks or interventions with which to
compare this QI proposal.
Theoretical Model
Milio’s Framework of Prevention was used to guide this QI project through its six
identified propositions (Milio, 1976; see Appendix F). Milio’s propositions, generally, examine
how individuals or populations can be influenced to improve or change their health choices.
Applying these propositions specifically to preventive care prior to international travel can help
identify reasons for lack of preventive care and recognize ways to improve uptake of that care
individually or through population health strategies.
Translation Model
The Ottawa Model of Research Use (OMRU) framework was utilized for quality
improvement and has three fundamental elements which must be addressed as this assessment
affects the project’s uptake and implementation success (Logan & Graham, 1998; see Appendix
G). The innovation element addressed the evidence to support this quality improvement plan the screening of patients for upcoming travel. The second fundamental element addressed
potential adopters which included: (a) primary care medical assistants (Mas) and providers; (b)
travel medicine referral team members; and (c) TMC office staff. The practice environment
element addressed structure which included an information technology (IT) build, an increased
referral burden, and patient economic considerations. Through the linear diagram of the OMRU,
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interventions and adoption were assessed in a dynamic manner. Outcomes are addressed in the
results portion of this paper while ongoing evaluation and changes may be considered for future
initiatives.
Methodology
Participants
All adult patients were to be screened for international travel during the rooming process
at each UPMC Pinnacle primary care visit. The rooming medical assistant (MA) was to ask the
screening question which was built into the EMR. Inclusion criteria was all adult patients (≥18
years of age) presenting for a primary care appointment with a provider, while exclusion criteria
eliminated patients less than 18 years of age and patients roomed during EMR “downtime” – any
time that the EMR was not functional or available to staff.
Participants under the age of 18 (n=28,063) were deleted from the entire retrieved data
set (N=457,865) because they did not meet inclusion criteria. Of the remaining participants (N =
429,802), missing demographic data was <1% for both gender and ethnicity with no missing data
for age or appointment type. This sample ranged in age from 18 to 105 years (mean = 56.8
years, SD = 17.2), was primarily female (57.3%, n = 246,420), white (87.9%, n = 372,594) and
were seen for a non-acute appointment (98.7%, n = 424,269) In comparing the demographics
between the pre-intervention group (n = 266.763) to the post-intervention group (n = 163,014),
statistically significant differences were found for both gender [x2(1), = 97.85, p = .000] and age
[pre-intervention, M = 57.5 (SD = 17.13) and post-intervention, M = 55.8 (SD = 17.39)],
t(340519) = 31.2, p = .000. Additional analysis of the complete data set revealed large amounts
of non-random missing data for the variables of interest (travel plans [yes/no] missing = 54.8%
[n=89,311] and referral offered [yes/no] missing = 98.9% [n=161,176]) from the post-
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intervention group [n = 163,014] due to lack of documentation of answers to the screening
questions. It was decided that the sample would be restricted to participants with complete data
and that a data set would be built to control for the two confounders (gender and age) while
maintaining all valid data of participants that did have complete information and a positive
referral to the TMC.
The quota sample was created by separating groups (pre- or post-), controlling for the
demographic variables of age and gender, and choosing individuals to construct equivalent
groups. The final data set consisted of two demographically equivalent groups (N = 200). This
process did maintain the integrity of the higher number of travel referral orders in the postintervention group (n=90) versus the pre-intervention group (n=13). Subjects in the preintervention group were seen in the primary care offices between August 2018 and mid-May
2019 while subjects in the post-intervention group were seen in the primary care offices between
late May 2019 and January 2020. It should be noted that the ethnicity of the total sample was so
predominantly White (87.9%) that it was not possible to create equal representation among
ethnicities in the quota sample (Appendix H). However, increased representation of minority
ethnicities was attempted in the quota sample build with 70% White and 30% Black/Other.
Setting
The UPMC Pinnacle network supports over 50 primary care offices which care for a
diverse urban, suburban, and rural population spread across ten central Pennsylvania counties
(UPMC, 2019a). The TMC is a specialty clinic (as part of Infectious Disease) within the UPMC
Pinnacle network. Positive attributes of this project included: (a) low complexity with “yes/no”
responses to screening questions, (b) compatibility with simple inclusion as part of current
practice as questions were embedded into the EMR for MAs to read and record responses to
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during rooming, (c) feasibility with EMR prompts consistent across all offices within the
electronic medical system, (d) clear, evidence-based recommendations as previously noted, and
(e) UPMC Pinnacle leadership support. Barriers included: (a) staffing workload and associated
lack of compliance, (b) minimal opportunities to educate staff due to competing health system
priorities, (c) lack of opportunity to trial implementation, and (d) massive implementation with
limited opportunity for ongoing evaluation. To overcome barriers, the project manager
attempted frequent communication during initial implementation with the Outpatient Chief
Quality Officer (OPCQO), Primary Care office managers, and the TMC manager to discuss
concerns or roadblocks during implementation, as well as ongoing electronic education to
Primary Care office managers during initial implementation. However, data analysis exposed
under compliance of rooming staff and associated documentation.
Tools
The screening tool, developed by the project manager and the OPCQU, was based on
evidence-based recommendations for improvement because no screening tool was previously
embedded in the EMR, nor was a tool found in the literature review (see Appendix I).
Intervention
Screening was to be obligatory as it was built into the electronic requirements of the
rooming process at each adult primary care appointment. During each primary care visit the
patients were roomed by the MA, who was to ask the pre-populated EMR screening question “Do you have upcoming travel planned outside of the United States?” - and record the answer(s)
in the EMR. If the screening was positive, an additional statement and question automatically
populated in the EMR – “International travel has unique health risks; however, there is
preventive care available to help decrease your risk of getting sick. Can we refer you to our
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Travel Medicine Clinic for care?” If the patient agreed, a referral to the TMC was automatically
triggered for the provider, who signed any appropriate referrals to the TMC (see Process Flow
Chart in Appendix J).
For this project, the project manager provided verbal education with an accompanying
PowerPoint presentation to the office managers and physician team leaders during a regularly
scheduled Team Lead Meeting. The office managers were to educate the MAs in their office on
the screening implementation. The providers, who received the electronic prompt to sign any
appropriate TMC consults, were sent evidence-based research (written by the project manager)
for the change with an authoritative directive through email from the OPCQO (see Appendix K).
Additionally, the project manager provided educational materials for the patients on travel risks
and prevention (see Appendix L).
Data Collection
Quantitative, de-identified, retrospective data of all patients seen at UPMC Pinnacle
primary care sites was requested through the IT department for EMR extraction with
demographic variables including (a) gender, (b) age, (c) ethnicity, and (d) type of appointment
(acute versus non-acute). Data was requested and received for all UPMC Pinnacle primary care
appointments from August 2018 through January 2020. Additional data requested and received
included all referrals to the TMC and screening question assents (from this QI project
intervention) in the EMR. The number of referrals to the UPMC Pinnacle TMC over the 8
months prior to screening implementation were compared to data collected for eight months
post-implementation. Additionally, data was statistically analyzed and potential differences with
referrals/non-referrals were sought in associated demographic information (gender, age,
ethnicity, and reason for appointment – acute versus non-acute).
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Cost Analysis

There were no direct costs to the organization other than utilization of existing resources.
Minimal costs were donated by the Project Manager (see Appendix M).
Timeline
In April 2018, the project manager received proposal approval and completed
Institutional Review Board (IRB) submission for both UPMC Pinnacle and Messiah College;
both IRB approvals were granted within 2 weeks of submission. An aggressive timeline to
initiate the intervention was proposed due to UPMC Pinnacle’s enthusiasm for this QI project.
Thus, additionally in April 2019, the implementation team was educated, IT completed the
intervention build, and the screening tool was embedded into the system EMR. In May 2019,
education for patients was distributed to primary care offices, the UPMC Pinnacle Nursing
Research Council was updated (per system policy), and the screening tool was enabled in the
EMR to begin screening. Retrospective pre-implementation data were obtained through EMR
extraction in November 2019 and post-implementation data were extracted in April 2020. These
data were analyzed in June/July 2020 with final QI project outcomes written in July 2020 (see
Appendix N).
Ethics and Human Subject Protection
The Messiah College and UPMC Pinnacle IRB approvals were obtained prior to initiating
the DNP project. All participants were protected by the Health Insurance Portability and
Accountability Act of 1996 (HIPAA) which, among other guarantees, protects the privacy of
patients’ health information (Robert Wood Johnson Foundation [RWJF], 2013). Additionally,
the project manager and practice personnel conducting this project carefully followed regular
standards of care for practice in a primary care office. Information collected as part of
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evaluating the impact of this project was aggregated data from the project participants and did
not include any potential patient identifiers. The risk to patients participating in this project was
no different from the risks of patients receiving standard primary care. Participant
confidentiality was assured by extracting de-identified aggregate data from the EMR system.
This data was kept on a password protected/locked USB (only accessible by the project manager)
and in a locked office in the project manager’s home.
Results
Analysis and Evaluation
The quota sample in its entirety consisted of 200 adult patients seen at primary care visits
(100 in pre-intervention group, 100 in post-intervention group) with a mean age of 45.94 years
(SD = 13.7). Most of the subjects were female (51%, n = 102), white (70%, n = 140) and at a
non-acute primary care appointment (99.5%, n = 199; see Appendix O1). Assumptions for the
Chi-square test and the Independent Samples t-test were met.
Between the pre-intervention group and the post-intervention group, there were no
statistically significant differences for gender [x2(1) = .000, p = 1]; ethnicity [x2(1) = .000, p = 1];
appointment type [x2(1) = 1.005, p = .316]; or age [t(176) = 0.510, p = .611]. An analysis of the
only dependent variable, a travel medicine referral, examined any differences related to the
primary question of this project – in adult patients seen in primary care offices, does the
implementation of a screening question for upcoming international travel plans increase referrals
to the Travel Medicine Clinic - compared to no screening question for upcoming international
travel plans? There was a statistically significant greater number of referrals to the TMC in the
post-intervention group (n = 90) compared to the pre-intervention group (n = 13) [x2(1) = 118.7,
p = .000] with a large effect size (d = .770; See Appendix O2). Additional analysis examined the
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relationship between the primary intervention question (Do you have plans for upcoming
international travel?) and referrals to the Travel Medicine Clinic. The Chi-Square test of
association results indicated that asking about upcoming international travel plans does have a
statistically significant effect on referrals to the TMC (pre group: 0%, n = 0; post group: 93.8%,
n =75, x2(2) = 29.18, p = .000; see Appendix O3) with a strong positive association (r = .59; See
Appendix O4).
Discussion
Although the previously identified SMART goals were not fully achieved, the
statistically significant difference of TMC referrals in the post-intervention group, specifically
associated with the new screening question, demonstrated the value of screening for upcoming
international travel at routine medical appointments. This QI project, implemented consistently,
could continue to increase referrals to the TMC. A subsequent result may be an increase in
preventive care and a decrease in travel-related illness in the primary care population with
international travel plans, which was the main purpose of this project. Additionally, public
health may be protected through the prevention of secondary, travel-related illness.
Strengths of this project included the large size of the UPMC Pinnacle network which
includes a TMC employing providers educated, and specializing, in travel medicine. Limitations
included (a) the focus on travelers from one geographic area which limits generalizability of this
study’s data to other geographic locations, (b) a primarily White population of patients which
limits generalizability to more diversely ethnic populations, and (c) low screening rate/gaps in
data due to staff non-compliance in utilizing the screening intervention questions.
Recommendations for future research include initiating the intervention on a smaller
scale initially to ensure education with frequent audits of staff compliance to decrease gaps in
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data. A separate project could examine the participation of patients who receive a TMC consult
and their attendance at preventive appointments including compliance with recommended
immunizations, protective medications, and self-care practices. Additionally, opportunities exist
to increase preventive, travel-related, care to foreign-born persons who return to their country of
birth to visit friends and relatives (VFRs) – this population suffers the highest rate of travelrelated morbidity but was not well-represented in this project. Nevertheless, the findings of this
QI project highlight the importance of screening patients for upcoming international travel to
improve referrals, for preventive care and protection of public health, to a TMC.
Conclusion
The core competency of independent practice for the nurse practitioner includes: (a)
health promotion; (b) disease prevention; and (c) health protection making this project applicable
for the nurse practitioner (Thomas et al., 2017). Thus, through screening for international travel
during routine primary care visits (which is not current practice), this QI project could improve
preventive care to the primary care population with international travel plans and protect public
health through prevention of secondary, travel-related illness.
International travel, which often has preventable health risks, had maintained popularity
until the COVID -19 global pandemic occurred. However, prior to the initiation of this project
there was a lack of research and QI strategies related to pre-travel medical consults, which assess
travelers’ risks, and adequate preventive care and education. This QI project screened for
prospective international travel and initiated appropriate referrals to the TMC for preventive
care. It is anticipated that this improvement in preventive care should minimize travelers’ health
risks as well as protecting public health through a decrease in secondary illness. The current
global pandemic has, currently, severely limited international travel through individual choice,
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business modifications, and government restrictions. It is unknown when or how frequently
international travel will resume; however, the speed with which COVID-19 was spread through
individuals traveling around the world should provide a cautionary tale for the medical
community and the public. There remains a need for improved awareness of international health
risks as ongoing global travel with already known disease risks resumes, and the evolution of
human-animal interface will likely potentiate additional novel infectious diseases (Perl & Price,
2020). Thus, screening for upcoming international travel and encouraging pre-travel medical
consults should be prioritized to minimize primary disease and prevent secondary illness.
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Appendix A

Table 1. SWOT Analysis
Strengths (internal)

Weaknesses (internal)

Healthcare organization has an Infectious
Disease Clinic

Referral team does not have the knowledge to
educate patients on risks if they decline referral

Healthcare organization has a Travel
Medicine Clinic

No ability to add additional resources at this
time to educate referral team

Large healthcare organization with wide
reach

Many staffing holes throughout organization

Many primary care offices to screen
patients for upcoming travel
Referral team to efficiently direct referrals
to Travel Medicine Clinic

PCPs do not have adequate knowledge to
advise travelers
PCP offices do not carry all necessary
immunizations for pre-travel preventive care
Lack of time by PCP during visit to assess
upcoming travel

Opportunities (internal)
Increased travel noted internationally
Large community of individuals visiting
family and relatives (VFRs) in the local
geographic region
Media often highlights infectious diseases
cases which increases awareness (i.e.
current coronavirus and Ebola)

Threats (external)
Lack of insurance coverage for preventive care
related to travel
Travel medicine preventive care and visit
requires private payment
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Appendix B
Root Cause Analysis Tool

Equipment/Supply
Many applicable
immunizations not
available in primary
care office

Environmental
Lack of advertising
for Travel Clinic
Increased need due to
increased international travel
Lack of time to assess during primary care visits

Lack of knowledge of primary care
providers in travel health
No education during referral
contact – just estimated costs

Travelers have lack of
awareness regarding
preventive care

People/Staff

Lack of screening process or assessment

Preventive Care for travel
not covered by insurance
Most destination countries do not require
immunization prior to entry

Policy/Procedure

Lack of preventive
care for
international travel
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Appendix C
SMART objectives:
1. EMR screening questions regarding upcoming international travel, asked by the medical
assistant, will be built into the rooming process template in the EPIC system and asked at
each adult primary care visit. This build will be completed by May 10, 2019.
2. 100% of adult patients presenting for a primary care visit will be screened for upcoming
international travel over an eight-month screening period using the EPIC system triggers
during the rooming process from May 2019 through January 2020.
3. 100% of adult patients who admit to upcoming international travel will be offered a
referral to the TMC by the medical assistant who is completing the rooming process.
4. 100% of patients who agree to the referral will have an automated referral directed to the
provider for the provider’s signature.
5. By screening every adult primary care patient at each visit for international travel, an
increased proportion of patients will be referred from primary care to the TMC for
preventive care and education over an 8-month period when compared to the proportion
of referrals from primary care to the TMC in the eight months prior to implementation of
screening.
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Appendix D

Identification

PRISMA Flow Diagram
Records identified through
database searching: Medline
Complete and CINAHL
Limits: English language; USA
geographic subset; years 20142020
(n = 731)

Additional records identified through
other sources: Centers for Disease
Control (CDC); International Journal
of Travel Medicine and Global
Health; Infectious Disease Alerts;
UpToDate
(n = 5)

Screening

Records after duplicates removed
(n = 722)

Included

Eligibility

Records screened
(n = 722)

Full-text articles
assessed for eligibility
(n = 39)

Articles included
(n = 17)

Records excluded
(n = 683)

Full-text articles excluded;
material not applicable to
PICO question
(n = 22)
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Appendix E
Evidence Summary Matrix

Article
#

1

Author, Publication Source,
& Date of Publication

Evidence Type and
Purpose

Sample Type, Size,
Setting

Freedman

Non-research:
Expert Opinion
– to provide
specialist
advice for
providers
performing
international
pre-travel
patient health
consultations

n/a

Research –
Nonexperimental;
comparative of
traveler
demographics
and trip
characteristics
with travel
plans as well as

Consecutive
sample of
15,440
patients from
5 travel
clinics in the
Boston Area
Travel
Medicine
Network
(BATMN)

The New England
Journal of Medicine
July 2016

2

Hamer
Mayo Clinic
Proceedings:
Innovations, quality,
and outcomes
July 2017

Study Findings

Provided a structured
and sequenced
approach using
standardized
protocols to provide a
pre-travel preventive
health consultation
for healthy adults
traveling to common
destinations. Advice
from a specialist is
recommended for all
other travelers

Limitations

Authors are
specialists in
Infectious Disease;
Due to constantly
changing global
health threats,
providers must
frequently consult
updated travel
medicine
information to
provide current and
accurate prevention
advice; thus, article
advice may not be
current.
Compared traveler
Focus on travelers
demographics and trip from only one
characteristics with
geographic area of
travel plans as well as the US (threat to
pretravel
external validity of
preparations;
selection bias and
Demographic
setting); missing
information – age,
responses for
sex, race/ethnicity,
certain variables;
country of origin,
lack of data on
year of arrival in the
reasons vaccines

Evidence
Level

Quality
Rating

V

A

III

B
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Article
#

3

Author, Publication Source,
& Date of Publication

Omodior
International Journal
of Travel Medicine
and Global Health
February 2017

30

Evidence Type and
Purpose

Sample Type, Size,
Setting

Study Findings

Limitations

pretravel
preparations

who were
medically
evaluated for
travel outside
the United
States from
March 2008 –
July 2010

U.S., parents’
countries of origin,
primary language;
Noted importance of
assessing unique
traveler and trip
characteristics to
improve
understanding of
clinic-specific
population health
risks based on clinic
geography as well as
individual travel
risks; Increased risks
noted for VFRs
(visiting friends and
relatives)

were not
administered
(threat to
instrument content
validity);
differences in
provider practice
(threat to
intervention
fidelity)

Research –
Nonexperimental;
descriptive – to
investigate
chikungunya
disease
awareness,
personal

Convenience
sample of 653
US adult
travelers who
visited any
one of 34
Caribbean
destinations

Only 35% of travelers
reported seeking out
information about
health risks at a
destination prior to
visiting to Caribbean;
Although
chikungunya disease
is a significant risk to

Study findings
limited to those
using an online
platform (threat to
external validity of
selection bias); No
survey question
differentiation
noted between

Evidence
Level

III

Quality
Rating

B
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Article
#

4

Author, Publication Source,
& Date of Publication

Angelo
Malaria Journal
July 2017

5

Freedman
UpToDate
November 2018

31

Evidence Type and
Purpose

Sample Type, Size,
Setting

protective
behaviors, and
health-seeking
behaviors of
US travelers to
destinations in
the Caribbean
Research –
Nonexperimental;
descriptive – to
describe
demographic
information,
travel details,
clinic visit
characteristics,
and disease
attributes of
travelers
diagnosed with
malaria after
travel to
malariaendemic areas
Non-research:
Clinical
Practice
Guidelines (for
travel
immunizations)

through an
online survey

Study Findings

Limitations

travelers in the
Caribbean, there is a
low level of disease
awareness among
travelers (30%) with
associated inadequate
prevention practices
Consecutive
53% of travelers did
sample of
not have a pre-travel
5689 travelers medical visit; 53%
diagnosed
were VFRs (visiting
with malaria
friends and relatives);
at
recommended
GeoSentinal
proactive action –
Global
increasing malaria
Surveillance
awareness, promoting
Network sites pre-travel medical
from March
visits, inquiring about
2003 - July
upcoming travel
2016
during routine
healthcare contacts to
increase prevention
measures

unique Caribbean
destinations
(threats to
instrumentation
content validity and
external validity of
setting)
May not be
representative of all
travelers with
malaria due to
specialized sites
record review
(threats to external
validity of selection
bias and setting);
no information on
malaria prophylaxis
taken or
compliance with
medication (threat
to external validity
of history and
treatment)

n/a

Guidelines
presented through
evidence-based
research from the
International
Society of Travel

Immunization
recommendations for
international travel;
travelers should
receive preventive
care prior to

Evidence
Level

Quality
Rating

III

A

IV

A
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Article
#

6

Author, Publication Source,
& Date of Publication

Walker
CDC

Evidence Type and
Purpose

Non-research:
Expert Opinion
(on travel
epidemiology)

32
Sample Type, Size,
Setting

n/a

June 2017

7

Fischer
Infectious Disease
Alert
June 20, 2017

Non-research:
n/a/
Consensus
statements from
International
Society of
Travel

Study Findings

Limitations

international travel; a
pre-travel consult
should be completed
by a specialized travel
clinic or a primary
care practice with
expertise in travel
medicine
International tourist
numbers are expected
to increase which
leads to an increased
risk for disease for the
traveler and for
secondary infections;
only 40% of returning
ill travelers reported
pretravel medical
visits

Medicine, the
Centers for Disease
Control and
Prevention; and the
World Health
Organization

Most primary care
providers are unable
to give accurate and
complete information
regarding pre-travel
preventive vaccines

Information
presented from
experts in
infectious disease
and/or travel
medicine.
Information
sources identified:
Centers for Disease
Control and
Prevention;
GeoSentinel
Surveillance
System; and United
Nations World
Tourism
Organization
Conference of
international travel
medicine
consultants – may
be biased toward
travel medicine

Evidence
Level

Quality
Rating

V

A

IV

B
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Article
#

Author, Publication Source,
& Date of Publication

Evidence Type and
Purpose

33
Sample Type, Size,
Setting

Medicine
conference
proceeding

8

Angelo
Journal of Travel
Medicine
2017

9

Harvey

Non-research:
Literature
review (of
studies that
included
international
travelers who
acquired a
travel-related
illness

n/a

Research –
Nonexperimental –
Descriptive – to

Consecutive
sample of
141,789
patients who

Study Findings

and
prevention/manageme
nt of travelers’
diarrhea; Professions
providing pre-travel
care must be
knowledgeable about
all aspects of travel
health, able to
effectively educate
travelers, and have
adequate time for
comprehensive care
Much data related to
illness from travel is
dated and with limited
generalizability; 4
studies were found to
provide valid
estimates on travelrelated illness –
between 43-79% of
travelers reported a
travel-related illness

The number of
patients evaluated
increased each
consecutive year; the

Limitations

Evidence
Level

Quality
Rating

specialists
providing pretravel care

All data from the 4
studies was drawn
from patients
which had a pretravel health
consultation – thus,
may not be
generalizable to all
travelers as most
who received a
consult were
traveling to higherrisk destinations
(Africa & Asia)
All data were from
GeoSentinel sites –
thus, may not be
generalizable to

V

A

III

A
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34

Author, Publication Source,
& Date of Publication

Evidence Type and
Purpose

Sample Type, Size,
Setting

Study Findings

Limitations

CDC – Morbidity and
Mortality Weekly
Report

summarize data
from patients
with confirmed
or probable
travel-related
illnesses

were
evaluated at
one of 22
GeoSentinel
Global
Surveillance
Network
medical sites
and were
diagnosed
with a travelrelated illness
from
September
1997 through
December
2011; limited
to patients
who had
traveled
across an
international
border within
the previous
ten years and
had sought
care for a
presumed
travel-related
illness

most common reason
for travel sited was
tourism; fewer than
half of all patients
(44%) reported a pretravel medical
consult; the most
common diagnosis
included was
unspecified diarrhea;
future efforts should
increase the number
of international
travelers who seek a
medical consult pretravel

entire traveling
population (threats
to external validity
of selection and
setting); cannot be
used to estimate
disease rates or
risks because of
lack of
denominator data;
Data coding
practices and the
GeoSentinel data
system have
changed over time
and may have
varied by site
(threat to
instrument
construct validity
and test-retest
reliability)

July 19, 2013
(sentinel study)

Evidence
Level

Quality
Rating
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Article
#

10

Author, Publication Source,
& Date of Publication

Evidence Type and
Purpose

Sample Type, Size,
Setting

Study Findings

Limitations

Hagmann

Research –
nonexperimental –
descriptive
demographics
included reason
for travel,
geographic area
of disease
acquisition, and
disease
spectrum

Consecutive
sample of
9624 US
travelers who
were
evaluated at
one US
medical clinic
in the
GeoSentinel
Surveillance
Network and
were
diagnosed
with a travelassociated
illness from
January 1,
2000 through
December 31,
2012
Consecutive
sample of
12,203
international
business
travelers who
were
evaluated at
one of the
GeoSentinel

Pre-travel advice was
sought by 45% of
returned ill travelers;
information on
purpose of travel and
destination represents
important information
to help inform
strategies in
improving preventive
pre-travel care;
highest percentage
captured (38%) had
traveled for tourism;
median travel
duration was 20 days;
GI illness were most
common (58%)

GeoSentinal data
only captures
information from
patients seen at the
specialty travel
clinics – not
primary, acute, or
emergency care
settings (threats to
external validity of
selection and
setting)

III

B

Malaria was the most
frequent diagnosis as
well as the most
common cause of
mortality; less than
half (46%) of the
travelers reported a
pre-travel medical
consultation; pretravel medical advice

GeoSentinal data
only captures
information from
patients seen at the
specialty travel
clinics – not
primary, acute, or
emergency care
settings (threats to
external validity of

III

A

Family Practice
2014

11

35

Chen
Journal of Travel
Medicine
2018

Research –
nonexperimental;
descriptive of
ill business
travelers post
international
travel

Evidence
Level

Quality
Rating
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Article
#

12

Author, Publication Source,
& Date of Publication

Lee
Tropical Diseases,
Travel Medicine and
Vaccines
2017

13

Tan
International Journal
of Travel Medicine
and Global Health
2017

Evidence Type and
Purpose

Non-research:
Clinical
Practice
Guidelines for
prevention of
travelassociated
illness in older
adults
Research: Nonexperimental;
comparative of
pre-travel
health care
utilization

36
Sample Type, Size,
Setting

Study Findings

Limitations

Surveillance
Network
clinics (64
clinics in 29
countries) and
were
diagnosed
with a travelassociated
illness from
January 1,
1997 through
December 31,
2014
n/a

is recommended but,
selection and
currently,
selection)
underutilized for
international business
travelers – needs to be
improved

Consecutive
sample of
2073 patients
(393 VFRs
and 1680
non-VFRs)
evaluated at

Compared to nonVFRs, VFRs often
have last-minute,
long-term travel
practices and lower
rates of vaccine
completion; authors

Elderly patients
should have a medical
consult prior to
international travel
for risk assessment
and guidance

Authors used the
GRADE system to
evaluate strength
and quality of
recommendations;
gaps in research
related to subgroup
of travelers
(elderly) with
special needs
Conducted at a
single clinic so
limited
generalizability
(threats to external
validity of selection
and setting); those

Evidence
Level

Quality
Rating

IV

B

III

B
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Article
#

14

Author, Publication Source,
& Date of Publication

Sanford
American Family
Physician

Evidence Type and
Purpose

Non-research:
Expert Opinion
(on a pretravel
medical
consult)

2016

15

LaRocque

Research: nonexperimental –
comparing

37
Sample Type, Size,
Setting

Study Findings

Limitations

Mayo Clinic
Travel and
Tropical
Medicine
Clinic from
January 1,
2012 through
December 31,
2013;
compared
pre-travel
utilization of
healthcare
between
VFRs and
non-VFRs
n/a

recommend that
during routine health
care visits, primary
care providers remind
VFR population to
seek pre-travel care if
needed

seen at clinic may
be more motivated
and literate related
to pre-travel care
(threats to external
validity of selection
and setting)

Physicians without
travel medicine
training or who do not
regularly perform pretravel consults should
refer any complex
patients to travel
medicine specialists

Only one author
has documented
travel medicine
expertise; reliable
sources are cited –
Travel and Tropical
Medicine Manual;
Centers for Disease
Control and
Prevention; and
Infectious Diseases
Society of America
Sample restricted
to single US
airport; small

Convenience Travelers to stillsample of
developing nations
1254 travelers have preventable

Evidence
Level

Quality
Rating

V

B

III

B
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#

Author, Publication Source,
& Date of Publication

Evidence Type and
Purpose

Sample Type, Size,
Setting

Study Findings

Journal of Travel
Medicine

travelers of
low/low-middle
income
companies and
uppermiddle/high
income
countries

to outside
countries at
Boston-Logan
International
Airport from
February –
August 2019

health risks; 54% of
survey respondents to
LLMI countries
pursued any health
information prior to
travel; less than 33%
of those who did
pursue health
information visited a
travel medicine
specialist

2010 (sentinel study)

16

38

Angelo
Journal of Travel
Medicine
2018

Research: Nonexperimental –
descriptive of
students’
characteristics

Limitations

sample size; few
travelers surveyed
who were planning
to travel to Asia
and Africa (higher
risk destinations)
(threats to external
validity of selection
and setting); survey
response rate not
noted (threat to
external validity of
selection
Convenience Increasing number of GeoSentinel data
sample of 432 students traveling to
only captures
students (ages resource-limited
information from
17-24) who countries; only 70%
patients seen at the
traveled inter- of ill students did
specialty travel
nationally for receive a health
clinics – not
school and
consult prior to travel; primary, acute, or
were given a all U.S. students
emergency care
confirmed
traveling
settings (threats to
travel-related internationally should external validity of
diagnosis at a receive a pre-travel
selection and
GeoSentinel consult with
setting); over half
travel clinic education, and
of the student
for illness
vaccines/chemoproph records were from
after
ylaxis when indicated only two clinics
returning
(threat to external
home to the
validity of setting)
U.S.

Evidence
Level

III

Quality
Rating

B
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Author, Publication Source,
& Date of Publication

Evidence Type and
Purpose

Sample Type, Size,
Setting

Zappas

Non-research:
Community
Standard for
nurse
practitioners
advising
traveling
patients

n/a

The Journal for Nurse
Practitioners
2019

Study Findings

It is important to
protect the health of
travelers as well as
the communities to
which they return; the
pre-travel consult
should be with a
provider who is wellversed in travel
medicine

Limitations

Reliable source
cited – Centers for
Disease Control
and Prevention;

Evidence
Level

Quality
Rating

V

* From: Dang, D., & Dearholt, S. L. (2018). Johns Hopkins evidence-based practice: Model and guidelines (3rd ed.). Indianapolis, IN: Sigma Theta Tau.
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Appendix F
Milio’s Framework of Prevention
Figure 1. Six propositions affecting health decisions

2. Limited
selection of
health habits actual and
perceived
options
1. Choices are
the result of
lack or excess
of health
resources

6. Health
education has
minimal effect
unless the
health options
are perceived as
novel

Individual
or
Population
Health
Decisions

5. Social
change is
influenced by a
large
percentage of
the population
adopting a
health choice

3.
Organizational
influence:
Choices and
awareness of
available
options

4. Choices
affecting health
(positive or
negative) are
influenced by
personal
resources

(Milio, 1776)
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Appendix G

Ottawa Model of Research Use (OMRU)

Reprinted from Center on Knowledge Translation for Disability and Rehabilitation Research. Retrieved from
http://ktdrr.org/ktlibrary/articles_pubs/ncddrwork/focus/focus18/figure2.html

Running head: IMPROVING PREVENTIVE CARE

42
Appendix H
Original Data Set Ethnicities

Chart 1. Ethnicities
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Appendix I
Screening Tool (EMR build)

(Triggers a Best Practice Advisory for Providers in Family Medicine and Internal Medicine)

! Referral to Travel Medicine Clinic due to planned upcoming international
travel
Order

Do Not Order

Ambulatory referral to Travel Clinic

Acknowledge Reason --------------------------------------------------------------------Patient declines

Other comment

43
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Appendix J
Process Flow Chart

Medical Assistant (MA) brings
patient to room and asks screening
questions. Project manager will
provide education for patient.

If screening is positive, MA asks if
patient will accept a referral to
Travel Medicine Clinic (TMC)

Screening is negative

If patient agrees to referral to TMC, documentation of assent
in electronic medical record triggers a Best Practice Advisory
to provider for Travel Medicine Clinic referral

Provider signs referral

Referral team calls patient to
discuss travel destination with
associated potential costs and
schedules pre-travel consult

Provider declines to sign referral
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Appendix K

Provider/Office Manager Education
Background: The popularity of international travel is evident as approximately 1.2
billion individuals traveled outside their own country in 2015 with anticipated estimates
increasing to 2 billion international travelers by 2030 (Freedman, Chen, & Kozarsky, 2016 and
Walker, LaRocque, & Sotir, 2017). Additionally, the number of individuals who travel to
emerging markets, often with inherent and unfamiliar health risks, is growing. This number
includes the large wave of immigrants to the U.S. – foreign-born persons who return to their
countries of birth to visit friends and relatives (VFRs) (Walker, LaRocque, & Sotir, 2017). All
travelers can expose themselves to unfamiliar diseases and risks outside of their own country, for
which they have received no preventive care or education, suffering morbidity and mortality as a
result (Angelo, Kozarsky, Ryan, Chen, & Sotir, 2017; Chen et al., 2018; Hagmann et al., 2014;
Laroque et al., 2010 and Omodior, Pennington-Gray, Holland, Thapa, & Kiousis, 2017).
Additionally, these travelers can carry nonendemic diseases across borders, exposing others to
secondary disease and increasing risks to public health (Walker, LaRocque, & Sotir, 2017).
Problem: Though 43-79% of international travelers reported illness during travel or after
returning home, up to 54% of international travelers never received a pre-travel health consult to
receive preventive care and education (Angelo et al., 2017a; Angelo et al., 2017b; Chen et al.,
2018; Hagmann et al., 2014; Laroque et al., 2010; and Omodior et al., 2017). Recommendations
by Angelo et al. (2017b) and Tan et al. (2017) are to proactively screen for international travel
during routine patient contacts. However, due to complex epidemiology and the dynamic nature
of travel medicine, unless a primary care provider (whose offices generally do not carry many of
the preventive immunizations recommended for certain travel destinations) can complete a
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comprehensive risk assessment and fully understands the traveler-specific, itinerary-specific, and
destination-specific risks, the patient should be referred to a travel medicine specialist (Aw et al.,
2014 and Fischer, 2017).
Process: The screening initiative will utilize an EPIC embedded tool and will be obligatory as it
will be built into the electronic requirements of the rooming process at each primary care
appointment. The medical assistant will ask the screening questions and record the answers in
the electronic record. A “positive” screen will post an additional question about referral to the
UPMC Pinnacle Travel Medicine Clinic. If a patient agrees, a Best Practice Advisory will
generate for providers who can sign any appropriate referrals to the Travel Medicine Clinic.
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Appendix L
Patient Education

Patient education taken from Centers for Disease Control and Prevention (CDC) travel
information – condensed and printed for patient distribution.
Note. From Centers for Disease Control and Prevention, 2020, https://www.cdc.gov/travel
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Appendix M
DNP Project Budget
Salaries/Wages (human resource costs)

Monthly
($)

•
•
•
•
•
•

Administrative Support
IT Systems Analyst
Practitioners
Medical Assistants
Travel Clinic Staff
Project Manager

Total Salary Costs (already incorporated - UPMC
Pinnacle)

Total
($)

$0
$0
$0
$0
$0
$0
(donated)
$0

$0
$0
$0
$0
$0
$0
$0

Startup Costs

Total
($)

•
•
•

$10
$145
-$145
$0

Copies of research proposal
Copies of educational handouts
Costs donated by Project Manager
Total Startup Costs
Capital Costs

Total
($)

•
•
•

Hardware
Equipment
Office Supplies
Total Capital Costs (already incorporated - UPMC Pinnacle)

$0
$0
$0
$0

Operational Costs

Total
($)

•
•

Electricity (already incorporated - UPMC Pinnacle)
Heat/AC (already incorporated - UPMC Pinnacle)

$0
$0

Total Project Expenses

$0
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Appendix N
Stages/GANNT Chart

Tasks

2019
Apr

Post-intervention

Intervention

Pre-intervention

Proposal approval
IRB submission and
approval
Educate implementation
team
Embed screening tool in
EPIC system
Enable screening tool in
EPIC
Educate patients on
purpose of screening
Communicate with team
leads, TMC manager,
providers (stakeholders)
Update nursing research
council on progress
Gather retrospective and
intervention data
Analyze data
Write final DNP project
Submit final project and
present to stakeholders

May

June

July

Aug

2020
Sept

Oct

Nov

Dec

Jan

Feb

Mar

Apr

May

June

July

Aug
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Appendix O
Data Analysis
Table 1: Comparison of Demographics Pre and Post Intervention Groups
Demographics
Group
Pre-intervention
Post-intervention
Age in yrs (SD)
52.3 (15.9)
50.81 (17.8)
Gender: female % (n)
50% (n = 50)
50% (n = 50)
Race: White % (n)
70% (n = 70)
70% (n = 70)
Appointment type: non-acute % (n)
100% (n = 100)
99% (n = 99)
Table 2. Travel Referral Order * Travel Plans Crosstabulation (without missing data)
Travel Plans
No
Yes
Total
Travel
No
Count
3
0
3
Referral
% within
100.0%
0.0%
100.0%
Order
travel referral
order
% within
37.5%
0.0%
3.6%
travel plans
Yes
Count
5
75
80
% within
6.3%
93.8%
100.0%
travel referral
order
% within
62.5%
100.0%
96.4%
travel plans
Total
Count
8
75
83
% within
9.6%
90.4%
100.0%
travel plans
% within
100.0%
100.0%
100.0%
travel referral
order
Table 3. Chi-Square Test
Value
Pearson Chi-Square
Continuity Correction
Likelihood Ratio
Fisher’s Exact Test
Linear-by-Linear Association
N of Valid Cases
a.
b.

df

29.180
19.408
15.227

1
1
1

Asymptotic
Significance
(2-sided)
.000
.000
.000

28.828
83

1

.000

Exact Sig.
(2-sided)

.001

2 cells (50.0%) have expected count less than 5. The minimum expected count is .29.
Computed only for a 2x2 table

Exact Sig.
(1-sided)

.001
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Table 4. Symmetric Measures
Value
Interval by Interval
Ordinal by Ordinal
N of Valid Cases

Pearson’s R
Spearman
Correlation

Asymptotic Approximate
Standard
Tb
Error
.593
.141
6.627
.593
.141
6.627
83

Approximate
Significance

